Resective Surgery for Mesial Temporal Lobe Epilepsy Associated with Hippocampal Sclerosis in Patients over 50 Years: a Case-control Study

Overview

Journal J Neurol

Specialty Neurology

Date 2024 Jul 28

PMID 39069564

Authors

Marta Garvayo

Sophie Dupont

Valerio Frazzini

Franck Bielle

Claude Adam

Yahia El Bendary

Marie Mere

Severine Samson

Alice Guesdon

Vincent Navarro

Bertrand Mathon

Affiliations

Soon will be listed here.

Abstract

Background: Mesial temporal lobe epilepsy associated with hippocampal sclerosis (MTLE/HS) is the most common cause of drug-resistant focal seizures and surgical resection is the primary treatment option, with seizure-free rates ranging from 60 to 80%. However, data on postsurgical seizure outcomes in patients ≥ 50 years of age are limited. This study aimed to assess the efficacy and safety of surgery in this age group compared to younger patients.

Methods: We performed a retrospective analysis of data from resective surgeries conducted in patients with MTLE/HS between 1990 and 2022. We focused on patients aged ≥ 50 years and compared the surgical safety and efficacy variables between this group and a control group of patients aged < 50 years through a case-control study.

Results: Among the 450 MTLE/HS patients who underwent surgery during the inclusion period, 61 (13.6%) were aged ≥ 50 years and matched with 183 younger patients, totaling 244 study participants. The two groups had similar characteristics. At the last follow-up (median 5.7 years), Engel I outcomes were achieved in 80.3% of the older patients and 81.4% of the younger patients, with no significant difference (p = 0.85). Postoperative cognitive and psychiatric outcomes did not differ between the groups. Major complication rates were also comparable, at 3.3% in the older group and 2.7% in the younger group (p = 0.83). The extratemporal ictal abnormalities observed on video-EEG were the only variable that demonstrated a significant association with an unfavorable seizure outcome in the older group (OR 9.3, 95% CI [1.8-47.6], p = 0.005).

Conclusions: This study provides grade 3 evidence that resective surgery for MTLE/HS patients aged ≥ 50 years is as effective and safe as it is for younger patients, and thus should be considered as the primary treatment option for drug-resistant cases.

References

Mathon B, Bedos Ulvin L, Adam C, Baulac M, Dupont S, Navarro V . Surgical treatment for mesial temporal lobe epilepsy associated with hippocampal sclerosis. Rev Neurol (Paris). 2015; 171(3):315-25. DOI: 10.1016/j.neurol.2015.01.561. View

Barbaro N, Quigg M, Ward M, Chang E, Broshek D, Langfitt J . Radiosurgery versus open surgery for mesial temporal lobe epilepsy: The randomized, controlled ROSE trial. Epilepsia. 2018; 59(6):1198-1207. DOI: 10.1111/epi.14045. View

Piccenna L, ODwyer R, Leppik I, Beghi E, Giussani G, Costa C . Management of epilepsy in older adults: A critical review by the ILAE Task Force on Epilepsy in the elderly. Epilepsia. 2022; 64(3):567-585. DOI: 10.1111/epi.17426. View

Wiebe S, Blume W, Girvin J, Eliasziw M . A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001; 345(5):311-8. DOI: 10.1056/NEJM200108023450501. View

Dalio M, Velasco T, Feitosa I, Assirati Junior J, Carlotti Junior C, Leite J . Long-Term Outcome of Temporal Lobe Epilepsy Surgery in 621 Patients With Hippocampal Sclerosis: Clinical and Surgical Prognostic Factors. Front Neurol. 2022; 13:833293. PMC: 9084624. DOI: 10.3389/fneur.2022.833293. View

Beghi E, Giussani G . Aging and the Epidemiology of Epilepsy. Neuroepidemiology. 2018; 51(3-4):216-223. DOI: 10.1159/000493484. View

Chibbaro S, Di Rocco F, Makiese O, Mirone G, Marsella M, Lukaszewicz A . Neurosurgery and elderly: analysis through the years. Neurosurg Rev. 2011; 34(2):229-34. DOI: 10.1007/s10143-010-0301-6. View

DAmico R, Cloney M, Sonabend A, Zacharia B, Nazarian M, Iwamoto F . The Safety of Surgery in Elderly Patients with Primary and Recurrent Glioblastoma. World Neurosurg. 2015; 84(4):913-9. DOI: 10.1016/j.wneu.2015.05.072. View

Grivas A, Schramm J, Kral T, von Lehe M, Helmstaedter C, Elger C . Surgical treatment for refractory temporal lobe epilepsy in the elderly: seizure outcome and neuropsychological sequels compared with a younger cohort. Epilepsia. 2006; 47(8):1364-72. DOI: 10.1111/j.1528-1167.2006.00608.x. View

10.

Delev D, Taube J, Helmstaedter C, Hakvoort K, Grote A, Clusmann H . Surgery for temporal lobe epilepsy in the elderly: Improving quality of life despite cognitive impairment. Seizure. 2020; 79:112-119. DOI: 10.1016/j.seizure.2020.05.003. View

11.

Zhang K, Shen M, Qiao N, Chen Z, He W, Ma Z . Surgical outcomes and multidisciplinary management strategy of Cushing's disease: a single-center experience in China. Neurosurg Focus. 2020; 48(6):E7. DOI: 10.3171/2020.3.FOCUS2067. View

12.

Mezjan I, Brissart H, Masson D, Vignal J, Aron O, Ferrand M . Epilepsy surgery for drug-resistant temporal lobe epilepsy in over-50 year-olds: Seizure outcome, surgical complications and neuropsychological outcome. Neurochirurgie. 2022; 68(5):510-517. DOI: 10.1016/j.neuchi.2022.04.001. View

13.

Srikijvilaikul T, Lerdlum S, Tepmongkol S, Shuangshoti S, Locharernkul C . Outcome of temporal lobectomy for hippocampal sclerosis in older patients. Seizure. 2011; 20(4):276-9. DOI: 10.1016/j.seizure.2010.12.008. View

14.

Murphy M, Smith P, Wood M, Bowden S, OBrien T, Bulluss K . Surgery for temporal lobe epilepsy associated with mesial temporal sclerosis in the older patient: a long-term follow-up. Epilepsia. 2010; 51(6):1024-9. DOI: 10.1111/j.1528-1167.2009.02430.x. View

15.

Boling W, Andermann F, Reutens D, Dubeau F, Caporicci L, Olivier A . Surgery for temporal lobe epilepsy in older patients. J Neurosurg. 2002; 95(2):242-8. DOI: 10.3171/jns.2001.95.2.0242. View

16.

Mathon B, Clemenceau S . Surgery procedures in temporal lobe epilepsies. Handb Clin Neurol. 2022; 187:531-556. DOI: 10.1016/B978-0-12-823493-8.00007-9. View

17.

Mathon B, Clemenceau S . Selective amygdalohippocampectomy via trans-superior temporal gyrus keyhole approach. Acta Neurochir (Wien). 2016; 158(4):785-789. DOI: 10.1007/s00701-016-2717-4. View

18.

Mathon B, Navarro V, Bielle F, Nguyen-Michel V, Carpentier A, Baulac M . Complications After Surgery for Mesial Temporal Lobe Epilepsy Associated with Hippocampal Sclerosis. World Neurosurg. 2017; 102:639-650.e2. DOI: 10.1016/j.wneu.2017.03.128. View

19.

Pimentel J, Peralta A, Campos A, Bentes C, Ferreira A . Antiepileptic drugs management and long-term seizure outcome in post surgical mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsy Res. 2012; 100(1-2):55-8. DOI: 10.1016/j.eplepsyres.2012.01.010. View

20.

Kim Y, Heo K, Park S, Huh K, Chang J, Choi J . Antiepileptic drug withdrawal after successful surgery for intractable temporal lobe epilepsy. Epilepsia. 2005; 46(2):251-7. DOI: 10.1111/j.0013-9580.2005.28004.x. View